Follicular Lymphoma
What's New
Last Posted: Oct 25, 2023
- Lymphoma In Patients With Inflammatory Bowel Disease: A Multicenter Collaborative Study Between Getaid And Lysa.
Marie Muller, et al. Journal of Crohn's & colitis 2023 0 - Prognostic relevance of clonal hematopoiesis in myeloid neoplastic transformation in patients with follicular lymphoma treated with radioimmunotherapy.
Zhuoer Xie, et al. Haematologica 2023 0 - Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms.
Sabrina Kalmbach, et al. Leukemia 2023 0 - Mutations Associated with Progression in Follicular Lymphoma Predict Inferior Outcomes at Diagnosis (Alliance A151303).
David A Russler-Germain, et al. Blood advances 2023 0 - Subclonal TP53 mutation are frequent and predict resistance to radio-immunotherapy in follicular lymphoma.
W Richard Burack, et al. Blood advances 2023 0 - Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma.
Ákos Nagy, et al. Journal of internal medicine 2023 0 - Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
Cristina Correia, et al. Blood cancer journal 2023 0 (1) 81 - Application of circulating tumour DNA in terms of prognosis prediction in Chinese follicular lymphoma patients.
Mengjing Zhao, et al. Frontiers in genetics 2023 0 1066808 - Genetic Subdivisions of Follicular Lymphoma Defined by Distinct Coding and non-coding Mutation Patterns.
Kostiantyn Dreval, et al. Blood 2023 0 - A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin's lymphoma (NHL): CALGB 50803 (Alliance).
Martin P, et al. Annals of oncology : official journal of the European Society for Medical Oncology 2017 0 (11) 2806-2812
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 01, 2024
- Content source: